• 1
    Copelan, E. A., Hematopoietic stem-cell transplantation. N. Engl. J. Med. 2006. 354: 18131826.
  • 2
    Ferrara, J. L. and Deeg, H. J., Graft-versus-host disease. N. Engl. J. Med. 1991. 324: 667674.
  • 3
    Allen, R. D., Staley, T. A. and Sidman, C. L., Differential cytokine expression in acute and chronic murine graft-versus-host-disease. Eur. J. Immunol. 1993. 23: 333337.
  • 4
    Troutt, A. B. and Kelso, A., Enumeration of lymphokine mRNA-containing cells in vivo in a murine graftversus-host reaction using the PCR. Proc. Natl. Acad. Sci. USA 1992. 89: 52765280.
  • 5
    Vogelsang, G. B., Lee, L. and Bensen-Kennedy, D. M., Pathogenesis and treatment of graft-versus-host disease after bone marrow transplant. Annu. Rev. Med. 2003. 54: 2952.
  • 6
    Yang, Y. G., Dey, B. R., Sergio, J. J., Pearson, D. A. and Sykes, M., Donor-derived interferon gamma is required for inhibition of acute graft-versus-host disease by interleukin 12. J. Clin. Invest. 1998. 102: 21262135.
  • 7
    Brok, H. P., Vossen, J. M. and Heidt, P. J., IFN-gamma-mediated prevention of graft-versus-host disease: pharmacodynamic studies and influence on proliferative capacity of chimeric spleen cells. Bone Marrow Transplant. 1998. 22: 10051010.
  • 8
    Murphy, W. J., Welniak, L. A., Taub, D. D., Wiltrout, R. H., Taylor, P. A., Vallera, D. A., Kopf, M. D. et al., Differential effects of the absence of interferon-gamma and IL-4 in acute graft-versus-host disease after allogeneic bone marrow transplantation in mice. J. Clin. Invest. 1998. 102: 17421748.
  • 9
    Afzali, B., Lombardi, G., Lechler, R. I. and Lord, G. M., The role of T helper 17 (Th17) and regulatory T cells (Treg) in human organ transplantation and autoimmune disease. Clin. Exp. Immunol. 2007. 148: 3246.
  • 10
    Baumgart, D. C. and Carding, S. R., Inflammatory bowel disease: cause and immunobiology. Lancet 2007. 369: 16271640.
  • 11
    Kebir, H., Kreymborg, K., Ifergan, I., Dodelet-Devillers, A., Cayrol, R., Bernard, M., Giuliani, F. et al., Human TH17 lymphocytes promote blood-brain barrier disruption and central nervous system inflammation. Nat. Med. 2007. 13: 11731175.
  • 12
    Carlson, M. J., West, M. L., Coghill, J. M., Panoskaltsis-Mortari, A., Blazar, B. R. and Serody, J. S., In vitro-differentiated TH17 cells mediate lethal acute graft-versus-host disease with severe cutaneous and pulmonary pathologic manifestations. Blood 2009. 113: 13651374.
  • 13
    Chen, X., Das, R., Komorowski, R., van Snick, J., Uyttenhove, C. and Drobyski, W. R., Interleukin 17 is not required for autoimmune-mediated pathologic damage during chronic graft-versus-host disease. Biol. Blood Marrow Transplant. 2010. 16: 123128.
  • 14
    Dander, E., Balduzzi, A., Zappa, G., Lucchini, G., Perseghin, P., Andre, V., Todisco, E. et al., Interleukin-17-producing T-helper cells as new potential player mediating graft-versus-host disease in patients undergoing allogeneic stem-cell transplantation. Transplantation 2009. 88: 12611272.
  • 15
    Iclozan, C., Yu, Y., Liu, C., Liang, Y., Yi, T., Anasetti, C. and Yu, X. Z., T helper17 cells are sufficient but not necessary to induce acute graft-versus-host disease. Biol. Blood Marrow Transplant. 2010. 16: 170178.
  • 16
    Kappel, L. W., Goldberg, G. L., King, C. G., Suh, D. Y., Smith, O. M., Ligh, C., Holland, A. M. et al., IL-17 contributes to CD4-mediated graft-versus-host disease. Blood 2009. 113: 945952.
  • 17
    Ratajczak, P., Janin, A., Peffault de Latour, R., Leboeuf, C., Desveaux, A., Keyvanfar, K., Robin, M. et al., Th17/Treg ratio in human graft-versus-host-disease. Blood 2010. 116: 11651171.
  • 18
    Tawara, I., Maeda, Y., Sun, Y., Lowler, K. P., Liu, C., Toubai, T., McKenzie, A. N. and Reddy, P., Combined Th2 cytokine deficiency in donor T cells aggravates experimental acute graft-vs-host disease. Exp. Hematol. 2008. 36: 988996.
  • 19
    Yi, T., Chen, Y., Wang, L., Du, G., Huang, D., Zhao, D., Johnston, H. et al., Reciprocal differentiation and tissue-specific pathogenesis of Th1, Th2, and Th17 cells in graft-versus-host disease. Blood 2009. 114: 31013112.
  • 20
    Yi, T., Zhao, D., Lin, C. L., Zhang, C., Chen, Y., Todorov, I., LeBon, T. et al., Absence of donor Th17 leads to augmented Th1 differentiation and exacerbated acute graft-versus-host disease. Blood 2008. 112: 21012110.
  • 21
    Rezvani, K., Mielke, S., Ahmadzadeh, M., Kilical, Y., Savani, B. N., Zeilah, J., Keyvanfar, K. et al., High donor FOXP3-positive regulatory T-cell (Treg) content is associated with a low risk of GVHD following HLA-matched allogeneic SCT. Blood 2006. 108: 12911297.
  • 22
    Huber, M., Heink, S., Grothe, H., Guralnik, A., Reinhard, K., Elflein, K., Hünig, T. et al., A Th17-like d evelopmental process leads to CD8+ Tc17 cells with reduced cytotoxic activity. Eur. J. Immunol. 2009. 39: 17161725.
  • 23
    Kondo, T., Takata, H., Matsuki, F. and Takiguchi, M., Cutting edge: phenotypic characterization and differentiation IL-17 T cells producing+of human CD8. J. Immunol. 2009. 182: 17941798.
  • 24
    Boniface, K., Blumenschein, W. M., Brovont-Porth, K., McGeachy, M. J., Basham, B., Desai, B., Pierce, R. et al., Human Th17 cells comprise heterogeneous subsets including IFN-{gamma}-producing cells with distinct properties from the Th1 lineage. J. Immunol. 2010. 185: 679687.
  • 25
    Chang, Y. J., Zhao, X. Y., Huo, M. R. and Huang, X. J., Expression profiles of adhesion molecules on naive T cells in bone marrow grafts of healthy donors treated with granulocyte colony-stimulating factor. Transplant. Immunol. 2009. 21: 228233.
  • 26
    Chen, S. H., Li, X. and Huang, X. J., Effect of recombinant human granulocyte colony-stimulating factor on T-lymphocyte function and the mechanism of this effect. Int. J. Hematol. 2004. 79: 178184.
  • 27
    Huang, X. J., Chang, Y. J. and Zhao, X. Y., Maintaining hyporesponsiveness and polarization potential of T cells after in vitro mixture of G-CSF mobilized peripheral blood grafts and G-CSF primed bone marrow grafts in different proportions. Transplant. Immunol. 2007. 17: 193197.
  • 28
    Jun, H. X., Jun, C. Y. and Yu, Z. X., In vivo induction of T-cell hyporesponsiveness and alteration of immunological cells of bone marrow grafts using granulocyte colony-stimulating factor. Haematologica 2004. 89: 15171524.
  • 29
    Sun, L. X., Ren, H. Y., Shi, Y. J., Wang, L. H. and ZX, Q., Recombinant human granulocyte colony-stimulating factor significantly decreases the expression of CXCR3 and CCR6 on T cells and preferentially induces T helper cells to a T helper 17 phenotype in peripheral blood harvests. Biol. Blood Marrow Transplant. 2009. 15: 835843.
  • 30
    Toh, H. C., Sun, L., Soe, Y., Wu, Y., Phoon, Y. P., Chia, W. K., Wu, J. et al., G-CSF induces a potentially tolerant gene and immunophenotype profile in T cells in vivo. Clin. Immunol. 2009. 132: 8392.
  • 31
    Hill, G. R., Olver, S. D., Kuns, R. D., Varelias, A., Raffelt, N. C., Don, A. L., Markey, K. A. et al., Stem cell mobilization with G-CSF induces Type-17 differentiation and promotes scleroderma. Blood 2010. 116:819828.
  • 32
    Huang, X. J., Liu, D. H., Liu, K. Y., Xu, L. P., Chen, H., Han, W., Chen, Y. H. et al., Haploidentical hematopoietic stem cell transplantation without in vitro T-cell depletion for the treatment of hematological malignancies. Bone Marrow Transplant. 2006. 38: 291297.
  • 33
    Lu, D.-P., Dong, L., Wu, T., Huang, X.-J., Zhang, M.-J., Han, W., Chen, H. et al., Conditioning including antithymocyte globulin followed by unmanipulated HLA-mismatched/haploidentical blood and marrow transplantation can achieve comparable outcomes with HLA-identical sibling transplantation. Blood 2006. 107: 30653073.